- Home
- ECOR vs VNRX Comparison
ECOR vs VNRX Comparison
Compare ECOR & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- VNRX
- Stock Information
- Founded
- ECOR 2005
- VNRX N/A
- Country
- ECOR United States
- VNRX United States
- Employees
- ECOR N/A
- VNRX N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ECOR Health Care
- VNRX Health Care
- Exchange
- ECOR Nasdaq
- VNRX Nasdaq
- Market Cap
- ECOR 65.0M
- VNRX 67.2M
- IPO Year
- ECOR 2018
- VNRX N/A
- Fundamental
- Price
- ECOR $16.49
- VNRX $0.64
- Analyst Decision
- ECOR Strong Buy
- VNRX Strong Buy
- Analyst Count
- ECOR 1
- VNRX 4
- Target Price
- ECOR $15.00
- VNRX $4.17
- AVG Volume (30 Days)
- ECOR 97.7K
- VNRX 524.2K
- Earning Date
- ECOR 11-13-2024
- VNRX 11-14-2024
- Dividend Yield
- ECOR N/A
- VNRX N/A
- EPS Growth
- ECOR N/A
- VNRX N/A
- EPS
- ECOR N/A
- VNRX N/A
- Revenue
- ECOR $23,327,000.00
- VNRX $1,285,827.00
- Revenue This Year
- ECOR $61.40
- VNRX $180.66
- Revenue Next Year
- ECOR $38.43
- VNRX $558.69
- P/E Ratio
- ECOR N/A
- VNRX N/A
- Revenue Growth
- ECOR 74.10
- VNRX 97.50
- 52 Week Low
- ECOR $5.25
- VNRX $0.43
- 52 Week High
- ECOR $15.25
- VNRX $1.23
- Technical
- Relative Strength Index (RSI)
- ECOR 69.93
- VNRX 49.57
- Support Level
- ECOR $13.22
- VNRX $0.57
- Resistance Level
- ECOR $14.87
- VNRX $0.68
- Average True Range (ATR)
- ECOR 1.34
- VNRX 0.08
- MACD
- ECOR 0.30
- VNRX -0.00
- Stochastic Oscillator
- ECOR 87.04
- VNRX 58.40
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.